Fulton Breakefield Broenniman’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-216
Closed -$227K 199
2024
Q3
$227K Hold
216
0.02% 172
2024
Q2
$227K Hold
216
0.02% 173
2024
Q1
$208K Buy
+216
New +$208K 0.02% 176
2020
Q3
Sell
-440
Closed -$274K 178
2020
Q2
$274K Buy
440
+4
+0.9% +$2.49K 0.03% 144
2020
Q1
$213K Buy
+436
New +$213K 0.03% 144